Skip to main content
. 2016 Nov 16;7(50):83735–83743. doi: 10.18632/oncotarget.13407

Figure 3.

Figure 3

Kaplan-Meier analysis depicting PSA progression-free survival, clinical/radiologic progression-free survival and overall survival according to A. ERG, B. SOX9 and C. ERG and SOX9 expression.